MissionIR Articles

Synthetic Biologics is a biotechnology company developing product candidates for serious infections and diseases. The company is developing a biologic for preventing C. diff infection as well as a series of monoclonal antibodies (mAbs) for…

DURECT is a specialty pharmaceutical company focused on developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil. The company’s proprietary oral, transdermal and injectable depot delivery…

Tengion is a leading clinical-stage regenerative medicine company focused on the development of its pioneering Organ Regeneration Platform. This platform is intended to harness the body’s intrinsic regenerative pathways to regenerate an array of native-like…

Tekmira Pharmaceuticals is a biopharmaceutical company and a leader in developing RNA interference (RNAi) therapeutics. The company is focused on advancing novel RNAi therapeutics and supplying pharmaceutical partners with its leading lipid nanoparticle delivery technology.…

Nymox Pharmaceutical is focused on researching and developing novel drugs and diagnostic products for the aging population. NX-1207, the company’s lead drug candidate, is a proprietary treatment for enlarged prostate or benign prostatic hyperplasia (BPH)…

ADVENTRX Pharmaceuticals is a biopharmaceutical company engaged in the development of proprietary product candidates for treating various diseases and conditions. ANX-188, the company’s lead product candidate, is initially being developed as a treatment for complications…

ACADIA Pharmaceuticals is a biopharmaceutical company with its focus on innovative treatments addressing unmet medical needs in neurological and related central nervous system disorders. Pimavanserin, which is in Phase III clinical development as a potential…

ZIOPHARM Oncology is a biopharmaceutical company engaged in developing and commercializing new cancer therapies. The company’s clinical programs include palifosfamide, currently being studied in two Phase 3 clinical trials; Ad-RTS IL-12, currently being tested in…

Apricus Biosciences is a biopharmaceutical company engaged in developing and marketing innovative treatments to help large patient populations across numerous high-demand therapeutic classes, including male and female sexual health. With three approved products, the company…

Affymax is a Palo Alto, Calif.-based biopharmaceutical company. The company’s focus is on discovering, developing and delivering innovative therapies to improve the lives of patients suffering with kidney disease and other serious, often life-threatening illnesses.…

Cempra is a clinical-stage pharmaceutical company engaged in developing antibiotics to meet critical needs in treating bacterial infectious diseases. The company’s two lead product candidates, solithromycin and CEM-102, are currently in advanced clinical development –…

Inovio Pharmaceuticals is revolutionizing vaccines for the prevention and treatment of today’s cancers and infectious diseases. The company’s SynCon vaccines are designed to provide universal cross-strain protection against both known and newly emergent unmatched strains…

Neuralstem possesses patented technology that enables the production of neural stem cells of the human brain and spinal cord in commercial quantities, as well as the ability to control the differentiation of these cells into…

Resverlogix is a clinical-stage cardiovascular company with an epigenetic platform technology that modulates protein production. The company is currently developing RVX-208, which is a first-in-class small molecule for treating atherosclerosis and the first BET bromodomain…

Athersys is a clinical stage biopharmaceutical company focused on discovering and developing therapeutic product candidates for extending and enhancing human quality of life. The company is currently developing its MultiStem cell therapy product and has…

ImmunoGen is a biotechnology company developing targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, coupled with its expertise in monoclonal antibodies and tumor biology. A TAP compound delivers one of ImmunoGen’s purpose-developed cancer-killing…

Zalicus is a biopharmaceutical company engaged in discovering and developing novel treatments for patients suffering with pain. The company’s portfolio of proprietary clinical-stage product candidates has entered into various revenue-generating collaborations with large pharmaceutical companies…